In early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy with or without chemotherapy and/or adjuvant hormone therapy, IFIT1 protein has been shown to act as a favorable prognostic marker for local control [31]. This evidence concerns the gene IFIT1 and breast carcinoma.